Antibe Therapeutics Inc(Pre-Merger) T.ATE

Alternate Symbol(s): ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

TSX:ATE - Post by User

Antibe Therapeutics Inc(Pre-Merger)

<< Previous

Bullboard Posts

Next >>

Post by Duster340on Sep 18, 2023 9:51am

114 Views

Post# 35641150

why buy on the open market

when you get grant of options, i wonder what they pay?

How do grant options work?

These options, which are contracts, give an employee the right to buy, or exercise, a set number of shares of the company stock at a preset price, also known as the grant price. This offer doesn't last forever, though. You have a set amount of time to exercise your options before they expire.

Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	Volume or Value
Sep 15/23	Sep 12/23	McNealey, Jennifer	Direct Ownership	Options	50 - Grant of options	15,000
Sep 15/23	Sep 12/23	Hoffman, Robert	Direct Ownership	Options	50 - Grant of options	15,000
Sep 15/23	Sep 12/23	Wu, Yung Cheng	Direct Ownership	Options	50 - Grant of options	15,000
Sep 15/23	Sep 12/23	Khouri, Amal	Direct Ownership	Options	50 - Grant of options	15,000
Sep 15/23	Sep 12/23	Flower, Roderick John	Direct Ownership	Options	50 - Grant of options	15,000
Sep 15/23	Sep 12/23	Macnee, Walter Minnes	Direct Ownership	Options	50 - Grant of options	15,000
Sep 15/23	Sep 12/23	Stegic, Ana	Direct Ownership	Options	50 - Grant of options	36,000
Sep 15/23	Sep 12/23	Curtis, Scott Wilson	Direct Ownership	Options	50 - Grant of options	136,000
Sep 15/23	Sep 12/23	Vaughan, David James	Direct Ownership	Options	50 - Grant of options	108,000
Sep 15/23	Sep 12/23	Stauffer, Joseph	Direct Ownership	Options	50 - Grant of options	108,000